Related Experiment Videos
Nociceptin/orpanin FQ and its receptor: a potential target for drug discovery
R Bertorelli1, G Calò, E Ongini
1Schering-Plough Research Institute, San Raffaele Science Park, Italy. rosalia.bertorelli@spcorp.com
Trends in Pharmacological Sciences
|September 9, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Therapeutic options in inflammatory bowel disease: experimental evidence of a beneficial effect of kinin B1 receptor blockade.
British journal of pharmacology·2008
Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice.
British journal of pharmacology·2008
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2.
The journal of peptide research : official journal of the American Peptide Society·2005
Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice.
Naunyn-Schmiedeberg's archives of pharmacology·2004
Bias from within: intracellular allosterism and the ICL2 hub.
Trends in pharmacological sciences·2026
Closing AI drug-regulatory gaps through harmonized oversight.
Trends in pharmacological sciences·2026
Midnolin-directed protein degradation beyond ubiquitin.
Trends in pharmacological sciences·2026
Deubiquitinases in mitophagy: therapeutic control of mitochondrial quality.
Trends in pharmacological sciences·2026
AI virtual cells for drug discovery and pharmacology.
Trends in pharmacological sciences·2026
Pyroptotic pores reopen the case for caspase inhibitors.
Trends in pharmacological sciences·2026
Structure-guided targeting of Plasmodium falciparum aminopeptidase P: exploiting S4' dimer-interface interactions for selective antimalarial drug design.
Expert opinion on therapeutic targets·2026
The quest to identify the molecular target of lithium.
Physical chemistry chemical physics : PCCP·2026
Design and syntheses of 4-aminoquinoline-thiazolidinone hybrids as anti-protozoal agents.
Frontiers in chemistry·2026
Computational screening of natural product inhibitor stargeting the MDM2-p53 interaction: docking and molecular dynamics insights for retinoblastoma therapy.
American journal of translational research·2026